Vertex Pharmaceuticals Incorporated (VRTX)
Last Price$484.20.8%
Market Cap$124.7B
11.5%
Industry median - 12.6%
5Y Historical average - 24.9%
N/A
Industry median - 10.6%
5Y Historical average - 54.5%
N/A
Industry median - (19.3%)
5Y Historical average - 22.4%
N/A
Industry median - (3.4%)
5Y Historical average - 36.8%
VRTX Growth Rating
Crunching data... Almost there!
VRTX Growth Metrics
Crunching data... Almost there!
Competing with VRTX Growth
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the Vertex Pharmaceuticals Incorporated (VRTX) revenue growth?
The Vertex Pharmaceuticals Incorporated (VRTX) revenue growth is 11.5%, which is lower than the industry median of 12.6% and the 5-year historical average of 24.9%.
What is the Vertex Pharmaceuticals Incorporated (VRTX) operating income growth?
The Vertex Pharmaceuticals Incorporated (VRTX) operating income growth is N/A, compared to the industry median of 10.6% and the 5-year historical average of 54.5%.
What is the Vertex Pharmaceuticals Incorporated (VRTX) EPS (Earnings Per Share) growth?
The Vertex Pharmaceuticals Incorporated (VRTX) EPS growth is N/A, compared to the industry median of (19.3%) and the 5-year historical average of 22.4%.
What is the Vertex Pharmaceuticals Incorporated (VRTX) Free Cash Flow (FCF) growth?
The Vertex Pharmaceuticals Incorporated (VRTX) Free Cash Flow growth is N/A, compared to the industry median of (3.4%) and the 5-year historical average of 36.8%.